DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Bruce Broussard - 4 Jim Rechtin - 4 Humana - 3 Broussard - 3 — - 2 Rechtin - 2 Jim Cramer - 1 they've - 1
Top related locs:
U.S Bengaluru The Louisville , Kentucky DaVita Group's California Kentucky UnitedHealth Danish
Top related orgs:
Humana - 3 Healthcare - 3 Medicare - 1 Revenue - 1 UnitedHealth - 1 CNBC - 1 Inc - 1 Thomson - 1

Search resuls for: "Jim Rechtin"


4 mentions found


☆ The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
  + stars: | 2023-11-01 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com   time to read: +7 min
"The story is on track, and I think you buy the stock," Jim Cramer said during Wednesday's Morning Meeting . Since its 2023 lows on July 13, Humana stock rallied more than 23% compared with a roughly 7% slide in the S & P 500 over the same stretch. Management's initial commentary on 2024 earnings and Medicare Advantage membership growth — discussed in more detail below — may also have left investors wanting. Humana also expects EPS growth in 2024 to fall on the lower end of its historical long-range 11%-to-15% target. Capital allocation Humana still expects to buy back about $1.5 billion worth of stock in 2023, finance chief Diamond said on the earnings call.
Persons: —, Jim Cramer, they've, UnitedHealth, Humana, Susan Diamond, Diamond, Bruce Broussard, Jim Rechtin, Broussard, Jim Cramer's, Jim Organizations: Medicare, Revenue, Humana, UnitedHealth, CNBC, Inc
☆ Insurer Humana's longtime CEO Broussard to step down next year
  + stars: | 2023-10-11 | by ( ) www.reuters.com   time to read: +1 min
Oct 11 (Reuters) - Humana (HUM.N) CEO Bruce Broussard will step down in the second half of 2024 after more than a decade at the helm, the insurer said on Wednesday and named healthcare veteran Jim Rechtin as his successor. Shares of the company, which grew seven-fold in value under 61-year-old Broussard, fell 2.8% to $486.4 in premarket trading. He led Humana to become the second-largest provider of Medicare Advantage in the U.S. by tripling its membership for the government-backed program to more than 5 million customers. His successor, Rechtin, will join Humana from Envision Healthcare, a U.S. provider of physicians where he is CEO and president. Broussard also helped the insurer expand beyond Medicare Advantage plans for older adults with the launch of healthcare services under the CenterWell brand in 2021.
Persons: Bruce Broussard, Jim Rechtin, Broussard, Rechtin, Kurt Hilzinger, Humana, Khushi, Arun Koyyur Organizations: Humana, Healthcare, Thomson Locations: U.S, Bengaluru
☆ Humana just tapped an Envision exec to be its next CEO as the insurance giant pushes deeper into clinics and home care
  + stars: | 2023-10-11 | by ( ) www.businessinsider.com   time to read: +6 min
Humana CEO Bruce Broussard will step down next year after more than a decade leading the health-insurance giant. Humana has tapped Jim Rechtin, head of Envision Healthcare, to be its next CEO. Weaving together insurance benefits with care delivery is meant to make healthcare easier for people to navigate and improve patients' health, Broussard said. One example is Humana's recent push into behavioral healthcare, Broussard said. That startup will eventually become part of Humana, Broussard said.
Persons: Bruce Broussard, Jim Rechtin, Broussard, —, Rechtin, " Broussard, Rafael Henrique, Humana Organizations: Healthcare, Humana, Indiana's DePauw University, Harvard, Getty, Aetna, Oak Street Health, Iora, One, General Atlantic Locations: The Louisville , Kentucky, DaVita, Group's California, Kentucky, UnitedHealth
☆ Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
  + stars: | 2023-10-11 | by ( Michelle Fox | ) www.cnbc.com   time to read: +3 min
Novo Nordisk — The Danish drugmaker stock added 5.5% after saying late Tuesday it was halting Ozempic's kidney disease treatment trial after a committee said an analysis showed signs of success. DaVita , Fresenius Medical Care , Baxter International — Shares of dialysis services providers DaVita and Fresenius Medical Care sank 18.4% and 19.6%, respectively, on Novo Nordisk's news. Exxon Mobil , Pioneer Natural Resources — Exxon Mobil shares fell more than 4% after the largest U.S. oil and gas producer agreed to buy shale rival Pioneer Natural Resources for $59.5 billion in an all-stock deal, or $253 per share. Amgen — The biopharma stock added 3.5% following an upgrade from Leerink to outperform. On Wednesday, B. Riley upgraded shares to buy from neutral, saying Coherent's silicon carbide business could be worth more than the Street's current estimate.
Persons: Eli Lilly, Bruce Broussard, Jim Rechtin, Amgen, David Risinger, Goldman Sachs, Jeffrey Brown, Tim Wentworth, Riley, Raymond James, — CNBC's Michael Bloom, Hakyung Kim, Yun Li, Lisa Han Organizations: Novo Nordisk, Novo Nordisk —, Baxter, Fresenius, Novo Nordisk's, Baxter International, Exxon Mobil, Natural Resources, Exxon, Exxon's, Mobil, Healthcare, Goldman, Walgreens, Alliance Locations: Danish, Novo
0 next >>
Total: 4